Eleven Biotherapeutics (EBIO – Snapshot Report) suffered a huge setback with its lead pipeline candidate failing in a late-stage study. Meanwhile, companies like bluebird (BLUE – Snapshot Report), Agios (AGIO – Snapshot Report) and Acceleron (XLRN – Snapshot Report) all got encouraging news on the regulatory front. Achillion (ACHN – Snapshot Report) struck a collaboration agreement with Johnson & Johnson […]
Barclays announced expanded coverage on seven biotech stocks Wednesday. Below are the new ratings and price targets along with comments from analyst Geoff Meacham.Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) was rated at Underweight with an $8 price target. The firm’s thesis was that “Achillion is likely to get left behind even with solid clinical data; a takeout may be one of […]
Barclays announced expanded coverage on seven biotech stocks Wednesday. Below are the new ratings and price targets along with comments from analyst Geoff Meacham.Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) was rated at Underweight with an $8 price target. The firm’s thesis was that “Achillion is likely to get left behind even with solid clinical data; a takeout may be one of […]
Small-cap biotechnology stocks offer some of the most breathtaking opportunities in the market, but some are better than others. For example, these three tiny biotech stocks are favorites among our Motley Fool experts, and that could mean they’re worth watching.Source: Portola Pharmaceuticals.: Warfarin’s decades long dominance as an anticoagulant used to treat heart disease and post-operative patients is waning, and […]
Source: Flickr user stockmonkeys.com .The pop-and-drop nature of the biotech industry makes owning stocks in the sector particularly dicey. But for investors willing to take on the risk of failure, a number of intriguing small-cap biotech companies are working on important new therapies that could make a big impact on patients’ lives and investors’ wallets. Here are three of thesecompanies.No. […]
View photo.Deutsche Bank on Thursday named its top Small-Cap Biotech picks for 2015. The top picks were selected because they were either a disruptive technology, a rare or orphan disease market, an unmet need market or a stock with a big-time catalyst.Here is what to watch for in Deutsche’s top picks.
PTC Therapeutics, Inc. (NASDAQ: PTCT)
Deutsche highlighted PTC Therapeutics as its […]
View photo.Deutsche Bank on Thursday named its top Small-Cap Biotech picks for 2015. The top picks were selected because they were either a disruptive technology, a rare or orphan disease market, an unmet need market or a stock with a big-time catalyst.Here is what to watch for in Deutsche’s top picks.
PTC Therapeutics, Inc. (NASDAQ: PTCT)
Deutsche highlighted PTC Therapeutics as its […]
Biotech stocks are among the market’s riskiest, but investors willing to accept the potential for pipeline failure might consider owning these five small-cap biotech stocks in 2015. All five have intriguing therapies in late-stage clinical trials, and three have high-profile big-cap partners.Source: Flickr user Carlos Gracia1. Proven performerInsys Therapeutics is already rewarding shareholders with rapid sales growth and profitability, but […]
View gallery.This week brings to close yet another year of gains for the stock market, the sixth straight year in this bull run.The benchmark S&P 500 started off 2014 at 1848 and as of Friday the index sat at 2088.Some of the top industries of the year include airlines, semiconductors, hospitals, aluminum, Internet service providers and residential REITs.Another industry cracking this […]
Stock market today, December 26, 2014: Good morning! U.S. stock futures for Friday, Dec. 26, forecasted a 31-point gain. On Wednesday, the Dow Jones Industrial Average rose six points to close at a record high. Investor optimism continued on news that the economy is strengthening. Third-quarter GDP hit 5%, while the U.S. economy has seen 2.7 million new jobs added this year – its best […]
